Nitric oxide theory of migraine

Clinical Neuroscience

Volumn 5, Issue 1, 1998, Pages 28-33

  Thomsen, Lars Lykke ^a,b   Olesen, Jes ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b European Federation of Neurological Societies ^*

^c Danish Headache Society

Author keywords

Headache; Histamine; Migraine; Nitric oxide; Nitroglycerine

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCIUM ANTAGONIST; FENFLURAMINE; GLYCERYL TRINITRATE; HISTAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROSTACYCLIN; RESERPINE; SEROTONIN; SEROTONIN ANTAGONIST;

ARTICLE; DRUG MECHANISM; EXTRAVASATION; HUMAN; HYPOXIA; MIGRAINE; NEUROGENIC INFLAMMATION; PLASMA; PRIORITY JOURNAL; THEORY;

BRAIN; CLINICAL TRIALS; HISTAMINE; HUMANS; MIGRAINE DISORDERS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NITROGLYCERIN;

EID: 0031932531     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Arregui A, Carera J, Leon-Velarde F, Paredes S, Viscarra D, Arbaiza D (1991): High prevalence of migraine in high-altitude population. Neurology 41:1668-1669.
2. Bellantonio P, Micieli G, Buzzi MG, Marcheselli S, Castellano AE, Rossi F, Nappi G (1997): Hemodynamic correlates of early and delayed responses to sublingual administration of isosorbide dinitrate in migraine patients: A transcranial Doppler study. Cephalalgia 17:183-187.
3. Blau JN, Dexter SL (1981): The site of pain origin during migraine attacks. Cephalalgia 1:143-147.
4. Brewerton TD, Murphy DL, Mueller EA, Jimerson DC (1988): Induction of migraine like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Ther 43:605-609.
5. Busija DW, Heistad DD, Marcus ML (1981): Continuous measurements of cerebral blood flow in anesthetized cats and dogs. Am J Physiol 241:H228-H234.
6. Busse R, Mülsch A (1990): Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275:87-90.
7. Buzzi G, Moskowitz M (1990): The antimigraine drug sumatriptan (GR43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99:202-206.
8. Dahl A, Russell D, Nyberg-Hansen R, Rootwell K (1989): Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke 20:1733-1736.
9. De-Marinis M, Feliciani M, Janiri L, Cerbo R, Agnoli A (1990): Increased reactivity to a metenkephalin analog in the control of autonmic responses in migraine patients. Clin Neuropharmacol 13:507-521.
10. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988): Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor. Proc Natl Acad Sci USA 85:9797-9800.
11. Drummond PD, Lance JW (1983): Extracranial vascular changes and source of pain in migraine headache. Ann Neurol 13: 32-37.
12. Feelisch M, Noack EA (1987): Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 139:19-30.
13. Fozard JR, Kalkman HO (1994): 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg's Arch Pharmacol 350: 225-229.
14. Friberg L, Olesen J, Iversen HK, Sperling B (1991): Migraine pain associated with middle cerebral artery dilatation: Reversal by sumatriptan. Lancet 338:13-17.
15. Friberg L, Olesen J, Skyhoj Olsen T, Karle A, Ekman R, Fahrenkrug J (1994): Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura. Cephalalgia 14:47-54.
16. Furchgott RF, Zawadzki JV (1980): The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376.
17. Garthwaite J (1993): Nitric oxide signalling in the nervous system. Neurosciences 5:171-180.
18. Garthwaite J, Charles SL, Chess-Williams R (1988): Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature 336:385-388.
19. Glover V, Ahmed F, Hussein N, Jarman J, Peatfield R (1996): Central 5-hydroxytrptamine supersensitivity in migraine. In Sandler M, Ferrari M, Harnett S (eds): Migraine: Pharmacology and Genetics. London: Chapman & Hall, pp 117-126.
20. 1c-like receptors. Naunyn Schmiedebergs Arch Pharmacol 347:471-477.
21. Goadsby PJ, Edvinsson L, Ekman R (1990): Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183-187.
22. Goadsby PJ, Kaube H, Hoskin KL (1992): Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res 595:167-170.
23. Gray DW, Marshall I (1992): Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat tharacic aorta by releasing nitric oxide. Br J Pharmacol 107:691-696.
24. Gruetter CA, Kadowitz PJ, Ignarro LJ (1981): Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrate and amyl nitrate. Can J Physiol Pharmacol 59:150-156.
25. Ignarro LJ, Lipton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA (1981): Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749.
26. Iversen HK (1992): N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther 52:125-133.
27. Iversen HK, Olesen J (1994): Nitroglycerin-induced headache is not dependent on histamine release. Support for a direct nociceptive action of nitric oxide. Cephalalgia 14:437-442.
28. Iversen HK, Olesen J (1996): Headache induced by a nitric oxide donor (nitrogrycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16:412-418.
29. Iversen HK, Olesen J, Tfelt-Hansen P (1989a): Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38:17-24.
30. Iversen HK, Holm S, Friberg L (1989b): Intracranial hemodynamics during intravenous nitroglycerin infusion. Cephalalgia 9(Suppl 10):84-85.
31. Iversen HK, Nielsen TH, Olesen J, Tfelt-Hansen P (1990): Arterial responses during migraine headache. Lancet 336: 837-839.
32. Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J (1992): Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 42:31-35.
33. Jansen-Olesen I, Ottosson A, Cantera L, Strunk S, Lassen LH, Olesen J, Mortensen A, Engel U, Edvinsson L (1997): Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1 and H2 receptors by RT-PCR. Br J Pharmacol 121:41-48.
34. Jensen K, Tuxen C, Pedersen-Bjerregård U, Jansen I, Edvinsson L, Olesen J (1990): Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine. Peptides 11:1127-1132.
35. Kiechle FL, Malinski T (1993): Nitric oxide biochemistry, pathophysiology and detection. Am J Clin Pathol 100:567-575.
36. Knowles RG, Moncada S (1994): Nitric oxide synthases in mammals. Biochem J 298:249-258.
37. Krabbe AÆ, Olesen J (1980): Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 8:253-259.
38. Lance JW (1991): 5-hydroxytrptamine and its role in migraine. Eur Neurol 31:279-281.
39. Lassen LH, Thomsen LL, Olesen J (1995): Histamine induces migraine via the H1-receptor. Support for the NO-hypothesis of migraine. Neuroreport 6:1475-1479.
40. 1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine. Eur J Pharmacol 49:335-340.
41. Lassen LH, Ashina M, Christinsen I, Ulrich V, Olesen J (1997): Nitric oxide synthase inhibition in migraine. Lancet 349:401-402.
42. Lüscher TF, Vanhoutte PM (1990): The Endothelium: Modulator of Cardiovascular Functions. Ann Arbor, Boston: CRC Press.
43. May A, Gijsman HJ, Wallnofer A, Jones R, Diemer HC, Ferran MD. Endothelin antagonist Bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain 1996; 67:375-378.
44. Mayer B (1994): Regulation of nitric oxide synthase and soluble guanylyl cyclase. Cell Biochem Funct 12:167-177.
45. Moncada S, Palmer RMJ, Higgs EA (1991): Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
46. Moskowitz MA (1993): Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43(Suppl 3):S16-S20.
47. Nichols FT III, Mawad M, Mohr JP, Stein B, Hilal S, Michelsen J (1990): Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. Stroke 21:555-559.
48. Olesen J, Iversen HK, Thomsen LL (1993): Nitric oxide supersensitivity. A possible molecular mechanism of migraine pain. Neuroreport 4:1027-1030.
49. Olesen J, Thomson LL, Iversen HK (1994): Nitric oxide is a key molecule in migraine and other vascular headaches. TIPS 15:149-153.
50. Olesen J, Thomsen LL, Lassen LH, Jansen-Olesen I (1995): The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15:94-100.
51. Ottosen ALP, Jansen I, Langemark M, Olesen J, Edvinsson L (1991): Histamine receptors in the isolated human middle meningeal artery. A comparison with cerebral and temporal arteries. Cephalalgia 11:183-188.
52. Palmer RMJ, Ferrige AG, Moncada S (1987): Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
53. Peatfield RC, Gawel MJ, Rose FC (1981): The effect of infused prostacyclin in migraine and cluster headache. Headache 21:190-195.
54. Pedersen-Bjerregård U, Nielse LB, Jensen K, Edvinsson L, Jansen I, Olesen J (1991): Calcitonin gene-related peptide, neurokinin A and substance P: Effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 12:333-337.
55. Rengasamy A, Johns RA (1991): Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions. J Pharmacol Exp Ther 259:310-316.
56. Roberts MHT (1992): 5-Hydroxytryptamine in nociception and antinociception. In Olesen J, Saxena PR (eds): 5-HT Mechanisms of Primary Headaches. New York: Raven Press, pp 69-76.
57. Schmetterer L, Wolzt M, Krejcy K, Graselli U, Findl O, Eichler HG, Singer EA (1996): Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerine headache model. Clin Pharmacol Ther 60:199-205.
58. Schmetterer L, Wolzt M, Graselli U, Findl O, Strenn K, Simak S, Kastner J, Eichler HG, Singer EA (1997): Nitric oxide synthase inhibition in the histamine headache model. Cephalalgia 17:175-182.
59. Shekar YC, Anand IS, Sarma R, Ferrari R, Wahi PL, Poole-Wilson PA (1991): Effect of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal bloodflow and hormone levels in congestive heart failure. Am J Cardiol 67:732-736.
60. Sicuteri F, Del Bene E, Poggioni M, Bonazzi A (1987): Unmasking latent dysnociception in healthy subjects. Headache 27: 180-185.
61. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF (1991): Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88:7773-7777.
62. Thomsen LL, Iversen HK (1993): Experimental and biological variation of three dimensional transcranial doppler measurements. J Appl Physiol 75:2805-2810.
63. Thomsen LL, Iversen HK, Brinck TA, Olesen J (1993): Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 13:395-399.
64. Thomsen LL, Iversen HK, Lassen LH, Olesen J (1994a): The role of nitric oxide in migraine pain: Therapeutic implications. CNS Drugs 2:417-422.
65. Thomsen LL, Kruuse C, Iversen HK, Olesen J (1994b): A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1:73-80.
66. Thomsen LL, Iversen HK, Olesen J (1995): Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia 15:109-116.
67. Toda N (1990): Mechanism underlying responses to histamine of isolated monkey and human cerebral arteries. Am J Physiol 258:H311-H317.
68. Wallace MN, Bisland SK (1994): NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neuroscience 59:905-919.
69. Wei EP, Moskowitz MA, Baccalini P, Kontos HA (1992): Calcitinon gene related peptide mediates nitroglycerin and sodium nitroprusside induced vasodilation in feline cerebral arterioles. Circ Res 70: 1313-1319.
70. Wennmalm Å, Peterson A (1991): Analysis of nitrite as a marker for endothelium-derived relaxing factor in biological fluids using electron paramagnetic resonance spectrometry. J Cardiovasc Pharmacol 17:s34-s40.